ENTITY
Xiamen Amoytop Biotech Co Ltd

Xiamen Amoytop Biotech Co Ltd (688278 CH)

37
Analysis
Health Care • China
Xiamen Amoytop Biotech Co., Ltd. operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products. Xiamen Amoytop Biotech markets its products primarily throughout China with limited overseas.
more
•28 May 2026 13:28

Quiddity Leaderboard STAR 50/100 Jun26: Final Expectations; ~US$2.6bn Combined One-Way Flows

The STAR50/100 Jun26 index review results will be confirmed after market close on Friday 29th May 2026. In this insight, we have presented our...

Share
•07 May 2026 18:53

STAR50 May 2026 Index Review Forecast

STAR50 May 2026 forecast: we expect Yuanjie Semiconductor, Dosilicon and Raytron Technology to enter, three current members to exit.

Logo
314 Views
Share
•23 Apr 2026 05:50

STAR50/STAR100 Index Rebalance Preview: Huge Outperformance, ETF Redemptions & Fast Entry Conundrum

There could be 4 changes for the STAR50 and 10 for the STAR100 in June. Fast Entry inclusions depend on the index committee. ETF redemptions...

Logo
347 Views
Share
•16 Apr 2026 16:52

Quiddity Leaderboard STAR 50/100 Jun26: Fate of Large IPO Fast-Track Additions Still a Question Mark

Recent large IPOs Moore Threads (688795 CH) and MetaX (688802 CH) could get added on a fast-track basis unless the index provider overrules them...

Share
•01 Apr 2026 15:26

STAR50 Index Earning Revision (Mar): Xinjiang Daqo, TIANNENG BATTERY, Biwin Storage, TRANSSION

We analyzed STAR50's consensus for Mar 2026 and highlighted changes of EPS in Xinjiang Daqo, TIANNENG BATTERY, Biwin Storage, TRANSSION, CSI SOLAR,...

Logo
223 Views
Share
x